metoprolol has been researched along with Weight Loss in 5 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Weight Loss: Decrease in existing BODY WEIGHT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Addition of low-dose metoprolol to sibutramine therapy increased patient compliance to the treatment, and decreased the frequency and severity of side effects including hypertension and palpitations, without decreasing the drug efficacy or causing significant deleterious changes in metabolic parameters." | 5.11 | Effect of low-dose metoprolol in combination with sibutramine therapy in normotensive obese patients: a randomized controlled study. ( Baykan, M; Durmus, I; Erem, C; Ersoz, HO; Hacihasanoglu, A; Telatar, M; Ukinc, K, 2004) |
| "Obesity is a significant risk factor for hypertension and the cardiovascular sequelae of hypertension." | 2.69 | The effect of weight loss intervention on antihypertensive medication requirements in the hypertension Optimal Treatment (HOT) study. ( Adair, CT; Anderson, DC; Cameron, ME; Jones, DW; King, NS; Miller, ME; Willoughby, DL; Wofford, MR, 1999) |
| "On treatment with propylthiouracil and a beta-blocking agent, her symptoms resolved within one day, even though her free thyroxine level was still high." | 1.32 | Hyperthyroidism as a cause of persistent vomiting. ( Cools, BM; Hoogendoorn, EH, 2004) |
| "To discover whether in hypertensives with left ventricular hypertrophy (LVH) the increased muscle mass will completely regress under antihypertensive treatment and drug dosage can in consequence be reduced." | 1.29 | [Decreasing the antihypertensive dosage during longterm treatment and complete regression of left ventricular hypertrophy]. ( Behr, U; Franz, IW; Ketelhut, R; Tönnesmann, U, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ersoz, HO | 1 |
| Ukinc, K | 1 |
| Baykan, M | 1 |
| Erem, C | 1 |
| Durmus, I | 1 |
| Hacihasanoglu, A | 1 |
| Telatar, M | 1 |
| Hoogendoorn, EH | 1 |
| Cools, BM | 1 |
| Franz, IW | 1 |
| Behr, U | 1 |
| Ketelhut, R | 1 |
| Tönnesmann, U | 1 |
| Chen, Y | 1 |
| Chandler, MP | 1 |
| DiCarlo, SE | 1 |
| Jones, DW | 1 |
| Miller, ME | 1 |
| Wofford, MR | 1 |
| Anderson, DC | 1 |
| Cameron, ME | 1 |
| Willoughby, DL | 1 |
| Adair, CT | 1 |
| King, NS | 1 |
2 trials available for metoprolol and Weight Loss
| Article | Year |
|---|---|
Effect of low-dose metoprolol in combination with sibutramine therapy in normotensive obese patients: a randomized controlled study.
Topics: Adrenergic beta-Antagonists; Adult; Anthropometry; Appetite Depressants; Arrhythmias, Cardiac; Cyclo | 2004 |
The effect of weight loss intervention on antihypertensive medication requirements in the hypertension Optimal Treatment (HOT) study.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bloo | 1999 |
3 other studies available for metoprolol and Weight Loss
| Article | Year |
|---|---|
Hyperthyroidism as a cause of persistent vomiting.
Topics: Abdominal Pain; Adrenergic beta-Antagonists; Adult; Chronic Disease; Diagnosis, Differential; Female | 2004 |
[Decreasing the antihypertensive dosage during longterm treatment and complete regression of left ventricular hypertrophy].
Topics: Adult; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Echocardiography; Exercis | 1996 |
Daily exercise and gender influence postexercise cardiac autonomic responses in hypertensive rats.
Topics: Animals; Atropine Derivatives; Autonomic Nervous System; Exercise Test; Female; Heart; Heart Rate; H | 1997 |